Metabolic markers associated with high mannose glycan levels of therapeutic recombinant monoclonal antibodies

Journal of Biotechnology
Sohye KangPavel V Bondarenko

Abstract

High mannose (HM) glycan levels on secreted monoclonal antibodies can be influenced by external factors, including osmolality and copper deficiency, and by intrinsic factors determined by different cell lines. In order to identify the metabolic markers associated with HM glycan levels, metabolomics analysis was performed to assess the changes in the extracellular metabolites of recombinant cell lines at different time points during fed-batch production process. Ornithine was identified as the common metabolic marker influenced by both external and intrinsic factors when eight different medium conditions and eight different cell lines exhibiting different levels of HM were compared. A strong correlation was also observed between HM and mRNA expression levels of arginase 1, an enzyme that catalyzes the conversion of arginine to ornithine. The results from functional validation study showed that the supplementation of ornithine to the culture medium leads to an increased level of HM, while reduced concentration of spermine, a downstream product of ornithine metabolism, leads to a decreased level of HM. Additional metabolic markers correlating with HM glycan levels were identified from eight-cell line comparison analysis. A common ...Continue Reading

References

Dec 5, 1975·Biochimica Et Biophysica Acta·G F MunroE L Verderber
Nov 1, 1974·The British Journal of Ophthalmology·K Takki, O Simell
Jan 1, 1980·Metabolism: Clinical and Experimental·J W ForemanS Segal
Feb 3, 2000·Proceedings of the National Academy of Sciences of the United States of America·T WangD Valle
Dec 14, 2004·Biotechnology and Bioengineering·Danny Chee Furng WongMiranda Gek Sim Yap
Dec 17, 2005·Analytical Biochemistry·Silas G Villas-BôasAdrian Cookson
Feb 7, 2006·The Journal of Biological Chemistry·Anthony E Pegg
Oct 10, 2006·Biotechnology Letters·Rubén AlcázarTeresa Altabella
Apr 28, 2007·Nature Reviews. Drug Discovery·Robert A Casero, Laurence J Marton
Jul 8, 2008·Molecular Aspects of Medicine·Shelly C Lu
Aug 18, 2009·Cardiovascular Research·Sowndramalingam SankaralingamSandra T Davidge
Nov 11, 2009·Rapid Communications in Mass Spectrometry : RCM·William P K ChongYing Swan Ho
May 7, 2010·Molecular Immunology·Gregory C FlynnZhongqi Zhang
Apr 1, 1969·Archives of Disease in Childhood·I J HopkinsT G Maddison
Jul 30, 2011·Nature Protocols·Christopher A SellickAlan J Dickson
Jun 23, 2012·Nature Reviews. Molecular Cell Biology·Kelley W MoremenAlison V Nairn
Oct 5, 2013·The Journal of Clinical Investigation·Thomas J WangRobert E Gerszten

❮ Previous
Next ❯

Citations

Jan 9, 2016·Biotechnology Journal·Ioscani Jimenez Del ValDietmar Weilguny
Oct 23, 2016·Biotechnology Progress·Hongcheng LiuAlyssa Neill
Feb 20, 2018·Biotechnology and Bioengineering·Qiong WangMichael J Betenbaugh
Jan 30, 2021·Journal of the American Society for Mass Spectrometry·Craig JakesJonathan Bones
Jul 4, 2020·Trends in Biotechnology·Renato MastrangeliHorst Bierau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.